Journal
ORGANIC LETTERS
Volume 13, Issue 5, Pages 1068-1071Publisher
AMER CHEMICAL SOC
DOI: 10.1021/ol103112v
Keywords
-
Categories
Funding
- NIH [RO1-NIGMS]
- Amgen
- AstraZeneca
- GlaxoSmithKline
- GAANN
- FQRNT (Fonds Quebecois de la Recherche sur la Nature et les Technologies)
- U.S. Department of Energy [DE-AC02-06CH11357]
- Michigan Economic Development Corp. [085P1000817]
Ask authors/readers for more resources
An NHC-catalyzed, diastereo- and enantioselective dimerization of enals has been developed. The use of Ti(Oi-Pr)(4) is a key element for the reactivity and selectivity of this process. The cyclopentenes are obtained with high levels of diastereo- and enantioselectivity and their synthetic utility is demonstrated by functionalization of the product alkene.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
